The Multi-Manager UK Equity Income Fund is designed to provide investors with broad exposure to the UK equity market with a focus on income generation. The Fund aims to add value above the total return of the FTSE All Share index through active stock selection. The Fund will be in the IMA UK Equity Income Universe.
Name | % Net Assets |
---|---|
GlaxoSmithKline | 5.7% |
Royal Dutch Shell | 5.6% |
Vodafone | 4.4% |
British American Tobacco | 3.8% |
Unilever | 2.9% |
AstraZeneca | 2.8% |
BT Group | 2.7% |
Imperial Tobacco | 2.7% |
HSBC Holdings | 2.5% |
Centrica | 1.9% |
Key | % Net Assets |
---|---|
GlaxoSmithKline | 5.7% |
Royal Dutch Shell | 5.6% |
Vodafone | 4.4% |
British American Tobacco | 3.8% |
Other | 80.5% |
Date | 09-May-2022 |
---|---|
NAV | 115.40p |
Currency | GBP |
Change | -2.60p |
% | -2.20% |
YTD change | 115.40p |
YTD % | n/a |
Fund Inception | 18/10/2004 |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.70% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research